The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been endorsed by the ANZCTR. Before participating in a study, talk to your health care provider and refer to this information for consumers
Trial details imported from ClinicalTrials.gov

For full trial details, please see the original record at https://clinicaltrials.gov/show/NCT01373424




Registration number
NCT01373424
Ethics application status
Date submitted
2/06/2011
Date registered
15/06/2011
Date last updated
16/06/2020

Titles & IDs
Public title
The Dystonia Coalition Natural History and Biospecimen Repository for Isolated Dystonias
Scientific title
Natural History and Biospecimen Repository for Dystonia; Comprehensive Rating Tools for Cervical Dystonia; Validity & Reliability of Diagnostic Methods & Measures of Spasmodic Dysphonia
Secondary ID [1] 0 0
U54TR001456
Secondary ID [2] 0 0
IRB00046266
Universal Trial Number (UTN)
Trial acronym
DCP
Linked study record

Health condition
Health condition(s) or problem(s) studied:
Dystonia 0 0
Condition category
Condition code
Musculoskeletal 0 0 0 0
Other muscular and skeletal disorders
Neurological 0 0 0 0
Other neurological disorders
Human Genetics and Inherited Disorders 0 0 0 0
Other human genetics and inherited disorders

Intervention/exposure
Study type
Observational
Patient registry
Target follow-up duration
Target follow-up type
Description of intervention(s) / exposure
Cervical dystonia - People diagnosed with cervical dystonia

Laryngeal dystonia - People diagnosed with laryngeal dystonia

Other voice disorders - People diagnosed with a voice disorder other than laryngeal dystonia - enrollment for this group is complete

Craniofacial dystonia - People diagnosed with craniofacial dystonia (including blepharospasm, meige syndrome, and oromandibular dystonia)

Limb dystonia - People diagnosed with limb dystonia

All other isolated dystonias - People diagnosed with any isolated dystonia not listed in descriptions of other cohorts

Myoclonus dystonia - People diagnosed with myoclonus dystonia

Dopa-responsive dystonia - People diagnosed with dopa-responsive dystonia

Comparator / control treatment
Control group

Outcomes
Primary outcome [1] 0 0
Observational - There is no primary outcome measure as this is an observational study.
Timepoint [1] 0 0
7 years

Eligibility
Key inclusion criteria
- Diagnosed with isolated dystonia or myoclonus dystonia or dopa-responsive dystonia

- To be included in laryngeal dystonia group, nasolaryngoscopy (voice box exam) must
have been completed to confirm diagnosis (this voice box exam is not part of the
study)
Minimum age
18 Years
Maximum age
No limit
Gender
Both males and females
Can healthy volunteers participate?
No
Key exclusion criteria
- Any evidence of a secondary cause for dystonia (other than myoclonus dystonia or
dopa-responsive dystonia)

- Less than 2 months since last botulinum toxin injection

- Inability to provide informed consent

- Significant medical or neurological conditions that preclude completing the
neurological exam

- Significant physical or other condition that would confound diagnosis or evaluation,
other than dystonia or tremor

Study design
Purpose
Duration
Selection
Timing
Statistical methods / analysis

Recruitment
Recruitment status
Recruiting
Data analysis
Reason for early stopping/withdrawal
Other reasons
Date of first participant enrolment
Anticipated
Actual
Date of last participant enrolment
Anticipated
Actual
Date of last data collection
Anticipated
Actual
Sample size
Target
Accrual to date
Final
Recruitment in Australia
Recruitment state(s)
Recruitment hospital [1] 0 0
Westmead Hospital - Westmead
Recruitment postcode(s) [1] 0 0
- Westmead
Recruitment outside Australia
Country [1] 0 0
United States of America
State/province [1] 0 0
Alabama
Country [2] 0 0
United States of America
State/province [2] 0 0
Arizona
Country [3] 0 0
United States of America
State/province [3] 0 0
California
Country [4] 0 0
United States of America
State/province [4] 0 0
Colorado
Country [5] 0 0
United States of America
State/province [5] 0 0
Florida
Country [6] 0 0
United States of America
State/province [6] 0 0
Georgia
Country [7] 0 0
United States of America
State/province [7] 0 0
Illinois
Country [8] 0 0
United States of America
State/province [8] 0 0
Iowa
Country [9] 0 0
United States of America
State/province [9] 0 0
Maryland
Country [10] 0 0
United States of America
State/province [10] 0 0
Massachusetts
Country [11] 0 0
United States of America
State/province [11] 0 0
Missouri
Country [12] 0 0
United States of America
State/province [12] 0 0
New Mexico
Country [13] 0 0
United States of America
State/province [13] 0 0
New York
Country [14] 0 0
United States of America
State/province [14] 0 0
North Carolina
Country [15] 0 0
United States of America
State/province [15] 0 0
North Dakota
Country [16] 0 0
United States of America
State/province [16] 0 0
Ohio
Country [17] 0 0
United States of America
State/province [17] 0 0
Pennsylvania
Country [18] 0 0
United States of America
State/province [18] 0 0
Tennessee
Country [19] 0 0
United States of America
State/province [19] 0 0
Texas
Country [20] 0 0
United States of America
State/province [20] 0 0
Virginia
Country [21] 0 0
United States of America
State/province [21] 0 0
Washington
Country [22] 0 0
United States of America
State/province [22] 0 0
Wisconsin
Country [23] 0 0
Canada
State/province [23] 0 0
Alberta
Country [24] 0 0
Canada
State/province [24] 0 0
Ontario
Country [25] 0 0
Canada
State/province [25] 0 0
Quebec
Country [26] 0 0
France
State/province [26] 0 0
Paris
Country [27] 0 0
Germany
State/province [27] 0 0
Luebeck
Country [28] 0 0
Italy
State/province [28] 0 0
Rome
Country [29] 0 0
United Kingdom
State/province [29] 0 0
London

Funding & Sponsors
Primary sponsor type
Other
Name
Hyder A. Jinnah, MD, PhD
Address
Country
Other collaborator category [1] 0 0
Government body
Name [1] 0 0
National Institute of Neurological Disorders and Stroke (NINDS)
Address [1] 0 0
Country [1] 0 0
Other collaborator category [2] 0 0
Government body
Name [2] 0 0
Office of Rare Diseases (ORD)
Address [2] 0 0
Country [2] 0 0
Other collaborator category [3] 0 0
Commercial sector/Industry
Name [3] 0 0
Allergan
Address [3] 0 0
Country [3] 0 0
Other collaborator category [4] 0 0
Other
Name [4] 0 0
Dystonia Study Group
Address [4] 0 0
Country [4] 0 0

Ethics approval
Ethics application status

Summary
Brief summary
Dystonia is a disorder characterized by excessive involuntary contraction of muscles with
repetitive and patterned movements. The isolated dystonias are the most common type of
dystonia and include Limb dystonias (like writer's cramp), Cervical dystonia (spasmodic
torticollis), Laryngeal dystonias (like spasmodic dysphonia), and Craniofacial dystonias
(like blepharospasm). The purpose of this study is to create resources to help learn more
about the isolated dystonias, myoclonus dystonia, and dopa-responsive dystonia and to develop
and validate various dystonia rating scales.
Trial website
https://clinicaltrials.gov/show/NCT01373424
Trial related presentations / publications
Public notes

Contacts
Principal investigator
Name 0 0
H. A. Jinnah, MD, PhD
Address 0 0
Emory University
Country 0 0
Phone 0 0
Fax 0 0
Email 0 0
Contact person for public queries
Name 0 0
Adam Kassem
Address 0 0
Country 0 0
Phone 0 0
404-727-3381
Fax 0 0
Email 0 0
akassem@emory.edu
Contact person for scientific queries

Summary results
For IPD and results data, please see https://clinicaltrials.gov/show/NCT01373424